October 15, 2012
By Jim Moore
Potential passengers grounded by motion sickness may soon have a more effective medication to treat that queasy feeling. NASA has adapted a tried-and-true cure for delivery via nasal spray, a method that brings more rapid relief.
The space agency announced Oct. 12 a deal with Epiomed Therapeutics Inc., a California firm that aims to bring intranasal scopolamine (INSCOP, as NASA calls it) to the wider world.
"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas," said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson Space Center.
A nasal delivery produced promising results during tests at the Naval Aerospace Medical Research Laboratory in Pensacola, Fla., and the U.S. Navy is also working on an agreement to collaborate with Epiomed.
Clinical trials must still be conducted to secure approval from the Food and Drug Administration.
The memory of a passenger who perished in an April 1945 airline accident continues to drive an effort to recognize notable achievements in aviation safety.
Santa Monica will appeal a court decision dismissing a lawsuit seeking to release the city from its obligation to keep SMO open and operating.
Female pilots and enthusiasts who belong to California's Palo Alto West Valley Flying Club formed the Women of West Valley for camaraderie and to encourage more to fly.
VOLUNTEER AT AN AOPA FLY-IN NEAR YOU!
SHARE YOUR PASSION. VOLUNTEER AT AN AOPA FLY-IN.
VOLUNTEER LOCALLY AT AOPA FLY-IN!
BE A PART OF THE FLY-IN VOLUNTEER CREW!